13 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Identification of a series of highly potent activators of the Nurr1 signaling pathway.
Novartis Institutes For Biomedical Research
Structural Optimization of Oxaprozin for Selective Inverse Nurr1 Agonism.
Ludwig-Maximilians-University of Munich
Development of a Potent Nurr1 Agonist Tool for In Vivo Applications.
Ludwig Maximilian University of Munich
Structure-Guided Design of Nurr1 Agonists Derived from the Natural Ligand Dihydroxyindole.
Ludwig Maximilian University of Munich
Targeting Nuclear Receptors in Neurodegeneration and Neuroinflammation.
Goethe University Frankfurt
Medicinal Chemistry and Chemical Biology of Nurr1 Modulators: An Emerging Strategy in Neurodegeneration.
Goethe University Frankfurt
Assessment of NR4A Ligands That Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1.
The Scripps Research Institute
Development and Profiling of Inverse Agonist Tools for the Neuroprotective Transcription Factor Nurr1.
Goethe University Frankfurt
Fragment-like Chloroquinolineamines Activate the Orphan Nuclear Receptor Nurr1 and Elucidate Activation Mechanisms.
Goethe University
Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease.
Sanofi